Literature DB >> 18788941

Differential regulation of GM1 and asialo-GM1 expression by T cells and natural killer (NK) cells in respiratory syncytial virus infection.

Martin L Moore1, Michael H Chi, Kasia Goleniewska, Joan E Durbin, R Stokes Peebles.   

Abstract

We previously reported that respiratory syncytial virus (RSV) infection increases lung CD8(+) T cell GM1 expression. The related lipid asialo-GM1 (ASGM1) is expressed by T cells in viral infection and by natural killer (NK) cells. The in vivo co-expression of GM1 and ASGM1 by immune cells is not defined. Here we analyzed lung lymphocyte GM1 and ASGM1 expression in RSV-infected mice. GM1 and ASGM1 were coordinately upregulated by activated CD8(+) T cells in RSV-infected BALB/c and C57BL/6 mice. In contrast, RSV infection had no effect on constitutively high NK cell GM1 expression, while increasing NK cell ASGM1 expression. GM1 and ASGM1 co-localized in lipid raft structures in NK and CD8(+) T cells sorted from the lungs of RSV-infected mice. Anti-ASGM1 Ab treatment of RSV-infected BALB/c mice depleted GM1/ASGM1-expressing NK cells and GM1/ASGM1-expressing T cells, reduced lung IFN-gamma levels, increased viral load, delayed viral clearance, and reduced illness. STAT1(-/-) mice are more susceptible to RSV replication and disease than wild-type mice. In RSV-infected STAT1(-/-) mice, anti-ASGM1 Ab altered cytokine levels, but in contrast to BALB/c mice, antibody treatment had no effect on viral load or illness. Taken together, GM1 and ASGM1 expression are differentially regulated by T and NK cells in RSV infection. Also, GM1/ASGM1-expressing cells are important for control of RSV in BALB/c mice, whereas STAT1(-/-) mice clear RSV by an alternative pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18788941      PMCID: PMC2952133          DOI: 10.1089/vim.2008.0003

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  75 in total

1.  Triton promotes domain formation in lipid raft mixtures.

Authors:  H Heerklotz
Journal:  Biophys J       Date:  2002-11       Impact factor: 4.033

Review 2.  Lubricating cell signaling pathways with gangliosides.

Authors:  Maria Laura Allende; Richard L Proia
Journal:  Curr Opin Struct Biol       Date:  2002-10       Impact factor: 6.809

3.  Role of plasma membrane lipid microdomains in respiratory syncytial virus filament formation.

Authors:  Lewis H McCurdy; Barney S Graham
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

4.  Distribution of the attachment (G) glycoprotein and GM1 within the envelope of mature respiratory syncytial virus filaments revealed using field emission scanning electron microscopy.

Authors:  Chris E Jeffree; Helen W McL Rixon; Gaie Brown; James Aitken; Richard J Sugrue
Journal:  Virology       Date:  2003-02-15       Impact factor: 3.616

5.  The role of IFN in respiratory syncytial virus pathogenesis.

Authors:  Joan E Durbin; Teresa R Johnson; Russell K Durbin; Sara E Mertz; Rafaella A Morotti; R Stokes Peebles; Barney S Graham
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

6.  Peripheral blood mononuclear cells from infants hospitalized because of respiratory syncytial virus infection express T helper-1 and T helper-2 cytokines and CC chemokine messenger RNA.

Authors:  Ralph A Tripp; Deborah Moore; Albert Barskey; Les Jones; Caminade Moscatiello; Harry Keyserling; Larry J Anderson
Journal:  J Infect Dis       Date:  2002-04-30       Impact factor: 5.226

7.  Respiratory syncytial virus assembly occurs in GM1-rich regions of the host-cell membrane and alters the cellular distribution of tyrosine phosphorylated caveolin-1.

Authors:  Gaie Brown; Helen W McL Rixon; Richard J Sugrue
Journal:  J Gen Virol       Date:  2002-08       Impact factor: 3.891

8.  Virus clearance and immunopathology by CD8(+) T cells during infection with respiratory syncytial virus are mediated by IFN-gamma.

Authors:  Tobias Ostler; Wendy Davidson; Stephan Ehl
Journal:  Eur J Immunol       Date:  2002-08       Impact factor: 5.532

9.  Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis.

Authors:  Julian P Legg; Imran R Hussain; Jill A Warner; Sebastian L Johnston; John O Warner
Journal:  Am J Respir Crit Care Med       Date:  2003-05-28       Impact factor: 21.405

Review 10.  Glycosphingolipid functions: insights from engineered mouse models.

Authors:  Richard L Proia
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-05-29       Impact factor: 6.237

View more
  14 in total

Review 1.  Role of glycosphingolipids in dendritic cell-mediated HIV-1 trans-infection.

Authors:  Wendy Blay Puryear; Suryaram Gummuluru
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

2.  STAT1 Represses Cytokine-Producing Group 2 and Group 3 Innate Lymphoid Cells during Viral Infection.

Authors:  Matthew T Stier; Kasia Goleniewska; Jacqueline Y Cephus; Dawn C Newcomb; Taylor P Sherrill; Kelli L Boyd; Melissa H Bloodworth; Martin L Moore; Kong Chen; Jay K Kolls; R Stokes Peebles
Journal:  J Immunol       Date:  2017-06-02       Impact factor: 5.422

3.  Natural killer cells are involved in acute lung immune injury caused by respiratory syncytial virus infection.

Authors:  Fengqi Li; Hanqing Zhu; Rui Sun; Haiming Wei; Zhigang Tian
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

4.  Isolation and characterization of canine natural killer cells.

Authors:  Helen T Michael; Daisuke Ito; Valarie McCullar; Bin Zhang; Jeffrey S Miller; Jaime F Modiano
Journal:  Vet Immunol Immunopathol       Date:  2013-06-28       Impact factor: 2.046

Review 5.  Natural killer cells in infection and inflammation of the lung.

Authors:  Fiona J Culley
Journal:  Immunology       Date:  2009-10       Impact factor: 7.397

6.  AsialoGM1 and integrin alpha2beta1 mediate prostate cancer progression.

Authors:  Severine Van Slambrouck; John Hilkens; Marco Bisoffi; Wim F A Steelant
Journal:  Int J Oncol       Date:  2009-10       Impact factor: 5.650

7.  Minimal PD-1 expression in mouse and human NK cells under diverse conditions.

Authors:  Sean J Judge; Cordelia Dunai; Ethan G Aguilar; Sarah C Vick; Ian R Sturgill; Lam T Khuat; Kevin M Stoffel; Jonathan Van Dyke; Dan L Longo; Morgan A Darrow; Stephen K Anderson; Bruce R Blazar; Arta M Monjazeb; Jonathan S Serody; Robert J Canter; William J Murphy
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

8.  The SPPL3-Defined Glycosphingolipid Repertoire Orchestrates HLA Class I-Mediated Immune Responses.

Authors:  Marlieke L M Jongsma; Antonius A de Waard; Matthijs Raaben; Tao Zhang; Birol Cabukusta; René Platzer; Vincent A Blomen; Anastasia Xagara; Tamara Verkerk; Sophie Bliss; Xiangrui Kong; Carolin Gerke; Lennert Janssen; Elmer Stickel; Stephanie Holst; Rosina Plomp; Arend Mulder; Soldano Ferrone; Frans H J Claas; Mirjam H M Heemskerk; Marieke Griffioen; Anne Halenius; Hermen Overkleeft; Johannes B Huppa; Manfred Wuhrer; Thijn R Brummelkamp; Jacques Neefjes; Robbert M Spaapen
Journal:  Immunity       Date:  2020-12-02       Impact factor: 31.745

9.  CD4+ and CD8+ T cells can act separately in tumour rejection after immunization with murine pneumotropic virus chimeric Her2/neu virus-like particles.

Authors:  Kalle Andreasson; Mathilda Eriksson; Karin Tegerstedt; Torbjörn Ramqvist; Tina Dalianis
Journal:  PLoS One       Date:  2010-07-19       Impact factor: 3.240

Review 10.  Too young to die? How aging affects cellular innate immune responses to influenza virus and disease severity.

Authors:  Christopher M Harpur; Mélanie A Le Page; Michelle D Tate
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.